Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › CLYM

SPHERA FUNDS MANAGEMENT LTD. position in CLYM

CLIMB BIO INC · Health Care

SPHERA FUNDS MANAGEMENT LTD. reported holding 483,747 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$6.3M, representing 0.88% of its reported portfolio and ranking #39 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed CLYM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)483.75K sh
Reported value held$6.31M
Portfolio Weight0.88%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SPHERA FUNDS MANAGEMENT LTD.'s CLYM position evolved

SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in CLYM in Q2 2024 at 215,179 shares (US$1.5M). The position peaked in Q2 2026 at 483,747 shares, worth US$6.3M. Across 9 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 483,747 shares valued at US$6.3M — an increase of 64,500 shares quarter over quarter.. Notable position changes include a 107% increase in Q3 2025 (shares rose 99% over the following quarter), a 114% increase in Q4 2025 (shares rose 71% over the following quarter), a 55% trim in Q1 2026 (shares rose 90% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 215.18K $1.53M New
Q3 2024 181.97K $926.23K Reduce
Q4 2024 251.94K $453.48K Add
Q1 2025 241.94K $295.16K Reduce
Q2 2025 209.84K $260.20K Reduce
Q3 2025 434.84K $874.02K Add
Q4 2025 932.25K $3.73M Add
Q1 2026 419.25K $2.87M Reduce
Q2 2026 483.75K $6.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLYM and 13F data

CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLYM

All CLYM fund holders →

FAQ

How long has SPHERA FUNDS MANAGEMENT LTD. held CLYM?

SPHERA FUNDS MANAGEMENT LTD. has disclosed CLYM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is SPHERA FUNDS MANAGEMENT LTD.'s current position in CLYM?

As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 483.75K shares of CLYM (CLIMB BIO INC), valued at $6.31M, representing 0.88% of its reported portfolio and ranking #39.

Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling CLYM?

In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. increased its position in CLYM. The position peaked in Q2 2026 at 483.75K shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.